Business Advisory Board
Chairman, Michael J. Fox Foundation for Parkinson’s Research; Partner Emeritus for Health Advances
For over 35 years Skip has been advising companies on business strategy, product commercialization, R&D planning and business development in the biotech, pharmaceutical and medical products industries. Skip serves as the Chairman of the Board at the Michael J. Fox Foundation for Parkinson’s Research and as an independent advisor to a number of clients in the life science industry.
Skip was a Managing Director at Health Advances. Joining in 1997, where he helped build a leading life-science focused management consulting firm with over 100 professional staff. Skip’s practice included Fortune 500 companies, venture-backed start-up companies and not-for-profit disease foundations and leading academic centers.
Prior to joining Health Advances, as Vice President for Commercial Development at the Massachusetts Biotechnology Research Institute (MBRI), Skip was involved in the founding of seven life sciences companies and created a unique technology licensing office representing eight academic research institutions and over $200 million in research. He helped found and served on the Board of t-Breeders, a cellular therapy company eventually purchased by Perkin Elmer.
Prior to MBRI, Skip was Vice President and Director of Worldwide Healthcare Consulting at Arthur D. Little, Inc. where his professional work involved technology planning, R&D management, and strategic alliances. Skip also worked in manufacturing and quality assurance for the sterile parenteral business at AstraZeneca plc.
Skip is an Adjunct Professor at the University of New England and is also a member of the College Corporation at the Massachusetts College of Pharmacy and Health Sciences where he earned his BS in Pharmacy and serves on the Board of Overseers for Mount Auburn Hospital. Skip earned his MBA at the Amos Tuck School at Dartmouth College.